金币
UID217728
帖子
主题
积分19262
注册时间2015-10-29
最后登录1970-1-1
听众
性别保密
|
欢迎您注册蒲公英
您需要 登录 才可以下载或查看,没有帐号?立即注册
x
A Biopharmaceutical Industry Perspective on the Control of Visible Particles in Biotechnology-Derived Injectable Drug Products
生物注射药品可见异物控制的生物药从业人员见解
Classification of Glass Particles in Parenteral Product Vials by Visual, Microscopic, and Spectroscopic Methods
通过视觉,显微镜和光谱学方法对肠道外药品瓶中的玻璃颗粒进行分类
Conducting Clinical Risk Assessments for Visible Particulate Matter in Parenteral Preparations
对肠道外制剂中可见异物进行临床风险评估
Analysis of Particulate Matter in Liquid-Finished Dosage Forms
液体剂型中的颗粒物质分析
Identification of Particles in Parenteral Drug Raw Materials
肠道外药物原料中异物的鉴别
Particulate Matter in Injectable Drug Products
注射剂中的颗粒物质
Achieving “Zero” Defects for Visible Particles in Injectables
在注射剂中实现可见异物“0”缺陷
网上找到的文献资源,仅供技术交流,谢绝商业用途。
|
-
-
A Biopharmaceutical Industry Perspective on the Control of Visible Particles in .pdf
1.47 MB, 阅读权限: 30, 下载次数: 199
售价: 1 金币 [记录]
-
-
Achieving “Zero” Defects for Visible Particles in Injectables.pdf
1.3 MB, 阅读权限: 30, 下载次数: 162
售价: 1 金币 [记录]
-
-
Analysis of Particulate Matter in Liquid-Finished Dosage Forms.pdf
2.63 MB, 阅读权限: 30, 下载次数: 171
售价: 1 金币 [记录]
-
-
Classification of Glass Particles in Parenteral Product Vials by Visual, Microsc.pdf
1.48 MB, 阅读权限: 30, 下载次数: 158
售价: 1 金币 [记录]
-
-
Conducting Clinical Risk Assessments for Visible Particulate Matter in Parentera.pdf
718.57 KB, 阅读权限: 30, 下载次数: 163
售价: 1 金币 [记录]
-
-
Identification of Particles in Parenteral Drug Raw Materials.pdf
1.67 MB, 阅读权限: 30, 下载次数: 154
售价: 1 金币 [记录]
-
-
Particulate Matter in Injectable Drug Products.pdf
470.94 KB, 阅读权限: 30, 下载次数: 174
售价: 1 金币 [记录]
|